Skip to main content

Outset Medical to Present at 42nd Annual Cowen Health Care Conference

Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that members of management will participate in a fireside chat at the 42nd Annual Cowen Health Care Conference on Tuesday, March 8, 2022 at 11:50am PT / 2:50pm ET.

A live and archived webcast of the fireside chat will be available on the “Investors” section of the Outset website at https://investors.outsetmedical.com/.

About Outset Medical, Inc.

Outset is a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis. The Tablo Hemodialysis System, FDA cleared for use from the hospital to the home, represents a significant technological advancement that transforms the dialysis experience for patients and operationally simplifies it for providers. Tablo serves as a single enterprise solution that can be utilized across the continuum of care, allowing dialysis to be delivered anytime, anywhere and by anyone. The integration of water purification and on-demand dialysate production enables Tablo to serve as a dialysis clinic on wheels, with 2-way wireless data transmission and a proprietary data analytics platform powering a new holistic approach to dialysis care. Tablo is a registered trademark of Outset Medical, Inc.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  210.83
+2.27 (1.09%)
AAPL  273.44
+1.30 (0.48%)
AMD  212.04
-1.80 (-0.84%)
BAC  51.35
+0.94 (1.86%)
GOOG  310.30
-0.62 (-0.20%)
META  648.91
+9.61 (1.50%)
MSFT  399.40
+10.40 (2.67%)
NVDA  195.68
+2.83 (1.47%)
ORCL  151.01
+4.87 (3.33%)
TSLA  415.50
+6.12 (1.49%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.